Phenotypic rescue of a Bacilysin-silenced strain of Bacillus Subtilis with Bacilysin supplementation

Download
2020-9
Ertekin, Ozan
Bacillus subtilis, the model organism for the gram positive bacteria, is distinguished for its secondary metabolite synthesis. Remarkably, most of these metabolites are small peptides which are generally synthesized non-ribosomally with multifunctional enzyme complexes. Bacilysin, a dipeptide composed of L-alanine and L-anticapsin, is the smallest peptide antibiotic which is produced by several enzymatical steps, however, its biosynthesis does not fully fit the general mechanisms of NRPSs. This small molecule acts specifically as an glucosamine-6-phosphate synthase inhibitor, thus interfering with cell wall formation in target microbes. Previously, it was found that the synthesis of bacilysin is governed by bacA operon and regulation of its synthesis is related with sporulation and quorum-sensing pathways. However, the effect of this dipeptide on its producer is obscure. To elucidate this effect, our research group constructed a bacilysin non-producer strain of B. subtilis named as OGU1. By the use of proteomic methods of 2DE MALDI-TOF MS/MS and nanoLC-MS/MS the differentially expressed proteins of OGU1 in comparison to parental strain PY79 was identified. The number of differentialy expressed proteins was rather high, being generaly underrepresented, and these proteins were mostly related with sporulation and germination pathways. In the present study, the results of comparative proteomics were validated with RT-qPCR analysis of selected 20 genes. Certain phenotypic deficiencies/inadequacies regarding spore pigmentation, lysozyme and chloroform resistance of spores, spore coat protein profile as well as spore germination kinetics were next observed in OGU1. Protein-free and bacilysin containing culture broth concentrate supplementation to growing OGU1 cultures partially or entirely rescued all of these deficient phenotypes, indicating a pleiotropic role of bacilysin on sporulation and germination of its producer.

Suggestions

Comparative transcriptomics of bacillus subtilisbacilysin-negative genotype with particular reference to bacilysin formation
Kocabay, Naz; Özcengiz, Gülay; Department of Molecular Biology and Genetics (2021-2-15)
The Gram-positive model prokaryote Bacillus subtilisis a non-pathogenic organism that is known for producing a wide variety of secondary metabolites with pharmacological andantimicrobial activities.The smallestdipeptideantibiotic bacilysin is among the many secondary metabolites that are produced by B. subtilis, and it is composed of L-alanine and L-anticapsin.As shown earlier by our research group, the synthesis of bacilysin is regulated by bacAoperon under the control of quorum sensing and s...
Cloning, characterization and heterologous expression of the aspartokinase and aspartate semialdehyde dehydrogenase genes of cephamycin C-producer Streptomyces clavuligerus
Tunca, S; Yilmaz, EI; Piret, J; Liras, P; Özcengiz, Gülay (Elsevier BV, 2004-09-01)
Carbon flow through the lysine branch of the aspartate biosynthetic pathway is a rate-limiting step in the formation of cephamycin C, a broad spectrum P-lactam antibiotic produced by Streptomyces clavuligerus. In this study, genes which encode the enzymes catalyzing the first two steps of the aspartate pathway, ask (aspartokinase) and asd (aspartate semialdehyde dehydrogenase), in S. clavuligerus NRRL 3585 were cloned and sequenced. Nucleotide sequencing and codon preference analysis revealed three complete...
Cloning and expression of gerE and glmS genes in Escherichia coli and Bacillus subtilis, and investigation of their possible interrelation with bacilysin biosynthesis
Akaysoy, Sergen; Özcengiz, Gülay; Department of Biology (2022-9-15)
Bacillus subtilis is the Gram-positive model bacterium that enzymatically produces the dipeptide antibiotic bacilysin. Bacilysin is the simplest bioactive peptide known composed of L-alanine at its N-terminal and L-anticapsin at its C-terminal. In a former work in our laboratory, a mutant strain of B. subtilis, namely OGU1 was constructed by bacA-targeted pMutin T3 insertion into the parental strain PY79 genome resulting in a genomic organization bacA′::lacZ::erm::bacABCDEF and unable to synthesize bacilysi...
Expression and activity analyses of industrially important extracellular enzymes produced by a bacilysin knock-out mutant of Bacillus Subtilis
Aytekin, Samet; Özcengiz, Gülay; Okay, Sezer; Department of Molecular Biology and Genetics (2018)
Bacilysin, the smallest peptide antibiotic known to date, is produced non-ribosomally by Bacillus subtilis by the collective actions of seven proteins transcribed from bacABCDEF operon and bacG gene. Bacilysin is a two-amino acid peptide composed of L-alanine and a modified amino acid, L-anticapsin. Bacilysin biosynthesis was shown to be strongly regulated by quorum sensing through the actions of global regulator proteins including Spo0K, Spo0H, Spo0A, ComQ/ComX, ComP/ComA as well as several Phr proteins, O...
Biological network modelling based on differentially expressed proteins in a bacilysin-deficient strain of bacillus subtilis
Kutnu, Meltem; Özcengiz, Gülay; Department of Molecular Biology and Genetics (2019)
Bacillus subtilis is a non-pathogenic, Gram-positive organism which is known for producing a broad range of secondary metabolites with pharmacological and antimicrobial activities. The dipeptide bacilysin is one of the many antibiotics synthesized by certain strains of B. subtilis, and it is composed of L-alanine and the non-proteinogenic amino acid L-anticapsin. Earlier silencing studies by our group have suggested that bacilysin acts as a pleiotropic molecule on its host. Therefore, the absence or lack of...
Citation Formats
O. Ertekin, “Phenotypic rescue of a Bacilysin-silenced strain of Bacillus Subtilis with Bacilysin supplementation,” M.S. - Master of Science, Middle East Technical University, 2020.